GlassScriptPhysician profile
Catherine Braun
NPI 1841597077
$3,605.86
in general payments reported to CMS, 2019-2025
32 companies · $904 in 2025
The $904 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $760 · 2022: $767 · 2023: $568 · 2024: $606 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,979 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,979.14 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.80 | 2021-2025 | |
| Glaxosmithkline, LLC. | $384.90 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $359.22 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $272.68 | 2021-2025 | Evenity, Otezla, Repatha |
| Lilly USA, LLC | $254.40 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Astellas Pharma US INC | $250.92 | 2024-2025 | Veozah |
| Pfizer INC. | $233.75 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $175.20 | 2022-2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $175.16 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $159.63 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Sumitomo Pharma America, INC. | $107.68 | 2025 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $83.03 | 2021-2023 | Camzyos |
| Sanofi Pasteur INC. | $71.68 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $67.58 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.78 | 2021-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $57.36 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $54.26 | 2022 | |
| Amarin Pharma, INC. | $46.17 | 2021 | |
| Philips North America LLC | $45.98 | 2024 | (Ck7) Extended Holter |
| Abbott Laboratories | $41.59 | 2021 | |
| Merck Sharp & Dohme LLC | $40.63 | 2023 | Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $38.05 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $37.15 | 2021 | |
| Idorsia Pharmaceuticals US INC | $29.39 | 2022-2023 | Quviviq |
| Inogen, INC. | $23.62 | 2025 | |
| Dexcom, INC. | $20.66 | 2025 | Dexcom G6 Transmitter |
| Kyowa Kirin, INC. | $18.98 | 2025 | |
| Lundbeck LLC | $17.24 | 2022 | |
| Renalytix Ai, INC. | $15.05 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Currax Pharmaceuticals LLC | $12.93 | 2023 | Contrave |
| Phathom Pharmaceuticals, INC. | $11.24 | 2025 | Voquezna |
| Echosens North America, INC. | $1.15 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.